0
0.5
1
1.5
2+
Recovery, dyspnea
-125%
Improvement
Relative Risk
Recovery, ague
-433%
Recovery, weakness
73%
Recovery, muscular pain
40%
Recovery, headache
38%
Recovery, sore throat
-71%
Recovery, sputum cough
12%
Recovery, dry cough
0%
Curcumin Askari et al. EARLY TREATMENT DB RCT
Is early treatment with curcumin beneficial for COVID-19?
Double-blind RCT 26 patients in Iran (November 2020 - April 2021)
Worse recovery with curcumin (not stat. sig., p=0.58)
c19early.org
Askari et al., Trials, June 2022
Favors curcumin
Favors control